Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasodilator therapy for chronic left ventricular failure

R B Kovick, J H Tillisch, S C Berens

    Circulation
    |February 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The flight surgeon and commercial aviation.

    The air surgeon's bulletin·2010
    Same author

    Advances in medicine in World War II.

    The Journal-lancet·2010
    Same author

    Concluding remarks.

    Bulletin of the New York Academy of Medicine·2009
    Same author

    A critique on complementary and alternative medicine.

    Journal of alternative and complementary medicine (New York, N.Y.)·2002
    Same author

    The relationship between obesity and mortality in patients with heart failure.

    Journal of the American College of Cardiology·2001
    Same author

    Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).

    The American journal of cardiology·2001

    Chronic oral vasodilator therapy, including isosorbide dinitrate and phenoxybenzamine, effectively manages refractory congestive heart failure. This treatment maintains beneficial hemodynamic improvements and provides symptomatic relief long-term.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Refractory congestive heart failure (CHF) poses significant management challenges.
    • Vasodilator therapy is a cornerstone in managing CHF, but long-term oral options require investigation.

    Purpose of the Study:

    • To evaluate the chronic effects of oral vasodilator therapy in patients with refractory congestive heart failure.
    • To assess the maintenance of hemodynamic benefits and symptomatic improvement with long-term oral vasodilator administration.

    Main Methods:

    • Acute hemodynamic assessment using intravenous sodium nitroprusside and sublingual isosorbide dinitrate.
    • Chronic oral therapy with isosorbide dinitrate and phenoxybenzamine for 3-21 months.
    • Repeat hemodynamic studies after a mean follow-up of seven months.

    Related Experiment Videos

    Main Results:

    • Acute therapy significantly reduced pulmonary capillary wedge pressure and systemic vascular resistance, while increasing cardiac index and stroke work index.
    • Chronic oral administration of isosorbide dinitrate and phenoxybenzamine maintained these favorable hemodynamic effects.
    • Patients experienced symptomatic improvement with minimal side effects during long-term therapy.

    Conclusions:

    • Chronic oral vasodilator therapy with isosorbide dinitrate and phenoxybenzamine is effective in maintaining hemodynamic improvements in advanced congestive heart failure.
    • This therapeutic approach offers sustained benefits and symptomatic relief for patients with refractory CHF.
    • Oral vasodilator therapy represents a viable long-term strategy for managing complex heart failure cases.